Remidio Innovative Solutions has been granted a US Patent for a 3D eye imaging technology built around a wearable form factor, such as smart glasses or a VR-style headset.
The device combines multiple eye examinations in one unit, including slit lamp imaging, fundus imaging and diffused anterior segment imaging. It can also capture images without pupil dilation by using infrared illumination instead of the bright visible light typically used by conventional instruments to examine the back of the eye.
“What used to need a slit lamp, an ophthalmoscope and several specialised exams can now fit into something worn like a pair of glasses. We’re not just making the equipment smaller; we’re changing where an eye exam can happen,” said Shanmuganathan Nagarajan, AVP of Research and Development at Remidio.
Remidio said the innovation also strengthens its larger Oculomics vision, which focuses on using retinal imaging to identify early signs of systemic health conditions.
The retina is one of the few parts of the body where blood vessels can be viewed directly, non-invasively and without radiation. As a result, growing research and clinical evidence support retinal imaging as an effective way to screen for conditions beyond eye disease, including cardiovascular disease, diabetes, kidney disease and neurodegenerative disorders.
By making advanced eye imaging more portable and eliminating the need for pupil dilation, the technology could help bring such screening beyond specialist clinics and closer to patients, with potential applications in community and, eventually, home-based care.
Remidio said a lighter, dilation-free imaging device could help bring such screening out of the specialist’s chair and closer to patients, and eventually into the home.
“We keep asking the same question: what does it take to bring care closer to the patient, closer to the consumer, even into the home? With Oculomics and a wearable device that consolidates slit lamp and fundus imaging into one unit, without needing a fixed instrument in a specialist’s room, is a great way to get there. It’s the kind of problem we’re always working on at Remidio, rethinking what the future of healthcare needs to look like,” said Anand Sivaraman, CEO of Remidio.
